<VariationArchive VariationID="11187" VariationName="NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup)" VariationType="Duplication" Accession="VCV000011187" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="3" DateLastUpdated="2024-06-23" DateCreated="2017-12-19" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26226" VariationID="11187">
      <GeneList>
        <Gene Symbol="ARX" FullName="aristaless related homeobox" GeneID="170302" HGNC_ID="HGNC:18060" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xp21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="25003694" stop="25015965" display_start="25003694" display_stop="25015965" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="25021810" stop="25034064" display_start="25021810" display_stop="25034064" Strand="-" />
          </Location>
          <OMIM>300382</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ARX">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ARX">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC109610631" FullName="aristaless related homeobox polyalanine expansion region" GeneID="109610631" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xp21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="25013530" stop="25013697" display_start="25013530" display_stop="25013697" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup)</Name>
      <CanonicalSPDI>NC_000023.11:25013543:CGGCCGCGGCTGCCGCGGCGGCCCC:CGGCCGCGGCTGCCGCGGCGGCCCCGGCCGCGGCTGCCGCGGCGGCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="25013543" stop="25013544" display_start="25013543" display_stop="25013544" variantLength="24" positionVCF="25013543" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCCGCGGCTGCCGCGGCGGCCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="25031660" stop="25031661" display_start="25031660" display_stop="25031661" variantLength="24" positionVCF="25031660" referenceAlleleVCF="G" alternateAlleleVCF="GCGGCCGCGGCTGCCGCGGCGGCCC" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139058.2" sequenceAccession="NM_139058" sequenceVersion="2" change="c.428_451dupGGGCCGCCGCGGCAGCCGCGGCCG">
            <Expression>NM_139058.2:c.428_451dupGGGCCGCCGCGGCAGCCGCGGCCG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.25031662_25031685dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.25031662_25031685dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.25013545_25013568dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.25013545_25013568dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008281.1" sequenceAccession="NG_008281" sequenceVersion="1" change="g.7382_7405dup">
            <Expression>NG_008281.1:g.7382_7405dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052655.1" sequenceAccession="NG_052655" sequenceVersion="1" change="g.116_139dup">
            <Expression>NG_052655.1:g.116_139dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_139058.3" sequenceAccession="NM_139058" sequenceVersion="3" change="c.428_451dup" MANESelect="true">
            <Expression>NM_139058.3:c.428_451dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_620689.1" sequenceAccession="NP_620689" sequenceVersion="1" change="p.Gly143_Ala150dup">
            <Expression>NP_620689.1:p.Gly143_Ala150dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA121408" DB="ClinGen" />
        <XRef ID="GTR000320450" DB="Genetic Testing Registry (GTR)" />
        <XRef Type="Allelic variant" ID="300382.0002" DB="OMIM" />
        <XRef Type="rs" ID="387906493" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup) AND Developmental and epileptic encephalopathy, 1" Accession="RCV000011937" Version="14">
        <ClassifiedConditionList TraitSetID="3089">
          <ClassifiedCondition DB="MedGen" ID="C3463992">Developmental and epileptic encephalopathy, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup) AND Partington syndrome" Accession="RCV000033212" Version="22">
        <ClassifiedConditionList TraitSetID="6538">
          <ClassifiedCondition DB="MedGen" ID="C0796250">Partington syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup) AND multiple conditions" Accession="RCV000700342" Version="6">
        <ClassifiedConditionList TraitSetID="31142">
          <ClassifiedCondition DB="MedGen" ID="C3463992">Developmental and epileptic encephalopathy, 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796244">Intellectual disability, X-linked, with or without seizures, arx-related</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup) AND not provided" Accession="RCV000487265" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-28" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_139058.3(ARX):c.428_451dup (p.Gly143_Ala150dup) AND Intellectual disability, X-linked, with or without seizures, arx-related" Accession="RCV001580167" Version="1">
        <ClassifiedConditionList TraitSetID="3090">
          <ClassifiedCondition DB="MedGen" ID="C0796244">Intellectual disability, X-linked, with or without seizures, arx-related</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-18" NumberOfSubmissions="5" NumberOfSubmitters="3" DateCreated="2017-12-19" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">10353782</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10398246</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11889467</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11971879</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12116222</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12376938</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12376946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12376949</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12640086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15151512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15200506</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15850492</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16078051</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16235064</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17331656</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17480217</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20506206</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">2080994</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21204215</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26029707</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3177452</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">5008734</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8826464</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-10-10">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-12-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6538" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5741" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 36</ElementValue>
                <XRef Type="MIM" ID="309510" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Partington X-linked mental retardation syndrome</ElementValue>
                <XRef ID="Partington+X-linked+mental+retardation+syndrome/5619" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Partington syndrome</ElementValue>
                <XRef ID="MONDO:0010654" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked, syndromic 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation-dystonic movements-ataxia-seizures syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked, with dystonic movements, ataxia, and seizures</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRX36</ElementValue>
                <XRef Type="MIM" ID="309510" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PRTS</ElementValue>
                <XRef Type="MIM" ID="309510" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRXS1</ElementValue>
                <XRef Type="MIM" ID="309510" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4235" />
                <XRef ID="4235" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="94083" DB="Orphanet" />
              <XRef ID="C0796250" DB="MedGen" />
              <XRef ID="MONDO:0010654" DB="MONDO" />
              <XRef Type="MIM" ID="309510" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31142" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2763" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 32</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 33</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 38</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 43</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 76</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 87</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, X-linked, with or without seizures, arx-related</ElementValue>
                <XRef ID="MONDO:0010317" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked 52</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0002" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRX29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX32</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX87</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLID29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX52</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
                <XRef Type="MIM" ID="300504" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX33</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX38</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX43</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX54</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX76</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5614" />
                <XRef ID="5614" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C0796244" DB="MedGen" />
              <XRef ID="MONDO:0010317" DB="MONDO" />
              <XRef Type="MIM" ID="300419" DB="OMIM" />
            </Trait>
            <Trait ID="1617" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INFANTILE SPASM SYNDROME, X-LINKED 1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 1</ElementValue>
                <XRef ID="MONDO:0010632" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked infantile spasms</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">West's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tonic spasms with clustering, arrest of psychomotor development and hypsarrhythmia on EEG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-Linked Infantile Spasm Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OHTAHARA SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ISSX1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DEE1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15298" />
                <XRef ID="15298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332436" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519156" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592989" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520998" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529356" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557944" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <XRef ID="C3463992" DB="MedGen" />
              <XRef ID="MONDO:0010632" DB="MONDO" />
              <XRef Type="MIM" ID="308350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3089" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1617" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INFANTILE SPASM SYNDROME, X-LINKED 1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 1</ElementValue>
                <XRef ID="MONDO:0010632" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked infantile spasms</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">West's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tonic spasms with clustering, arrest of psychomotor development and hypsarrhythmia on EEG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-Linked Infantile Spasm Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OHTAHARA SYNDROME, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ISSX1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DEE1</ElementValue>
                <XRef Type="MIM" ID="308350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15298" />
                <XRef ID="15298" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520980" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332436" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519156" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592989" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558371" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520998" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551668" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529356" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000557944" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <XRef ID="C3463992" DB="MedGen" />
              <XRef ID="MONDO:0010632" DB="MONDO" />
              <XRef Type="MIM" ID="308350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3090" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2763" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 32</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 33</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 38</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 43</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 76</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED 87</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, X-linked, with or without seizures, arx-related</ElementValue>
                <XRef ID="MONDO:0010317" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked 52</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300382.0002" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MRX29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX32</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX87</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLID29</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX52</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
                <XRef Type="MIM" ID="300504" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX33</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX38</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX43</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX54</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MRX76</ElementValue>
                <XRef Type="MIM" ID="300419" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5614" />
                <XRef ID="5614" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ARX-Related Disorders</Attribute>
              </AttributeSet>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C0796244" DB="MedGen" />
              <XRef ID="MONDO:0010317" DB="MONDO" />
              <XRef Type="MIM" ID="300419" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1107867" SubmissionDate="2019-01-29" DateLastUpdated="2019-04-17" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:1450310|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000572760" DateUpdated="2019-04-17" DateCreated="2017-04-27" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The c.428_451dup24 variant in the ARX gene has been reported multiple times previously in association with ARX-related disorders (StrÃ¸mme et al., 2002; Stepp et al., 2005; Laperuta et al., 2007). The c.428_451dup24 variant results in an in-frame addition of 8 Alanine residues in the second polyalanine tract of ARX, leading to a protein with 20 Alanine repeats instead of the normal 12 repeats. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. We consider it to be a variant of uncertain significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" alternateAllele="CGGCCGCGGCTGCCGCGGCGGCCCCGGCCGCGGCTGCCGCGGCGGCCC" referenceAllele="CGGCCGCGGCTGCCGCGGCGGCCC" start="25031660" stop="25031661" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_139058.2:c.428_451dup24</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="32170" SubmissionDate="2021-08-23" DateLastUpdated="2021-08-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300382.0002_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1" title="ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1" />
        <ClinVarAccession Accession="SCV000032170" DateUpdated="2021-08-27" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-05-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Developmental and Epileptic Encephalopathy 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Norwegian family described by Stromme et al. (1999), Stromme et al. (2002) found that 7 males with developmental and epileptic encephalopathy (DEE1; 308350), who were clinically diagnosed with infantile spasms/West syndrome, had a 24-bp duplication of nucleotides 429-451 in exon 2. This resulted in a polyalanine expansion from a tract of 12 alanines (amino acids 144-155) to a tract of 20 alanines.</Attribute>
              <Citation>
                <ID Source="PubMed">10353782</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
              <XRef DB="OMIM" ID="308350" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Partington Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stromme et al. (2002) found the same 24-bp duplication in the ARX gene in 2 families with X-linked mental retardation and in 2 families with Partington syndrome (PRTS; 309510). The 2 families in which Partington syndrome was caused by the 24-bp duplication in exon 2 were an Australian family described by Partington et al. (1988) and a Belgian family described by Frints et al. (2002).</Attribute>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3177452</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12376938</ID>
              </Citation>
              <XRef DB="OMIM" ID="309510" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Turner et al. (2002) reviewed the 2 families reported by Stromme et al. (2002) with X-linked mental retardation and the 24-bp duplication. They concluded that the variable expression of the mutation in individuals from both families included manifestations of both West and Partington syndromes. In addition, 1 individual had autism and 2 had autistic behavior, 1 of whom also had epilepsy.</Attribute>
              <Citation>
                <ID Source="PubMed">12376946</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stromme et al. (2003) described bilateral cyst-like cavities in both the cerebral and the cerebellar hemispheres. The patient was a 72-year-old man who lived in a home for the mentally handicapped. He was a member of a family in which X-linked mental retardation was due to a 24-bp duplication in exon 2 the ARX gene.</Attribute>
              <Citation>
                <ID Source="PubMed">12640086</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX36 (see 309510) family reported by Claes et al. (1996) with nonspecific X-linked mental retardation, Bienvenu et al. (2002) identified the 24-bp duplication in exon 2 of the ARX gene. Frints et al. (2002) suggested that the patients reported by Claes et al. (1996) had mild clinical features of PRTS.</Attribute>
              <Citation>
                <ID Source="PubMed">8826464</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12376949</ID>
              </Citation>
              <XRef DB="OMIM" ID="309510" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Polyalanine expansions in 1 of the 2 polyalanine tracts in exon 2 of the ARX gene represent the most frequently occurring mutation in the ARX gene, and interfamilial as well as intrafamilial variability are observed. Van Esch et al. (2004) reported a family in which 4 males with mental retardation had the ARX 24-bp duplication. The proband also had agenesis of the corpus callosum, transsphenoidal encephalocele, and a hypothalamic variant of partial anterior hypopituitarism. The patient had been reported by Grubben et al. (1990) as being born with a median cleft lip and palate and a transsphenoidal encephalocele. One of his affected uncles had dysarthria and dystonic movements of the hands, consistent with Partington syndrome. None of the patients had seizures. Van Esch et al. (2004) noted that congenital basal encephaloceles are very rare and are classified into 4 types, of which the transsphenoidal type is the least frequent (Suwanwela and Suwanwela, 1972). The reported endocrine defects associated with basal encephalocele involve mostly anterior pituitary hormones. The pattern of ARX expression in the brain during embryonic development suggested a causal role for the mutated protein in the origin of the encephalocele in the proband.</Attribute>
              <Citation>
                <ID Source="PubMed">15151512</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2080994</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">5008734</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Partington et al. (2004) reported 3 families with X-linked mental retardation due to the 24-bp duplication in the ARX gene. They reviewed the clinical findings in the 46 MRX patients from 9 families that had been reported with this mutation and noted that mental retardation ranged from mild to severe. Infantile spasms (West syndrome; 308350) occurred in 12.5% and less severe forms of seizures in 37.5%. Characteristic dystonic movements of the hands were seen in 63% and dysarthria in 54%. Partington et al. (2004) suggested that focal dystonia in association with mental retardation may be diagnostic of this mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">15200506</ID>
              </Citation>
              <XRef DB="OMIM" ID="308350" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Poirier et al. (2005) reported 2 brothers with mental retardation who had the 24-bp duplication in the ARX gene and whose healthy sister was heterozygous for the duplication. Their unaffected mother did not apparently carry the mutation, as determined by denaturing high-performance liquid chromatography (DHPLC) and by fragment size analysis, but semiquantitative fluorescent PCR revealed her to be a somatic mosaic, with 4% of her lymphocytes and 24% of her fibroblasts harboring the duplication. Because all 3 of her children received the affected X chromosome, Poirier et al. (2005) suggested that the level of mosaicism might be higher in the mother's germ cells.</Attribute>
              <Citation>
                <ID Source="PubMed">16078051</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stepp et al. (2005) identified the 24-bp duplication in affected individuals from 4 of 11 unrelated families designated as MRX29, MRX32, MRX33, and MRX38 with X-linked mental retardation (300419). The findings suggested that the 24-bp duplication is the most common mutation in nonsyndromic XLMR families linked to Xp22.1.</Attribute>
              <Citation>
                <ID Source="PubMed">15850492</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Laperuta et al. (2007) identified the 24-bp duplication of the ARX gene in 5 affected men from an Italian family designated MRX87 with X-linked mental retardation (300419). There was marked intrafamilial variation with cognitive deficits ranging from moderate to severe. There were no dysmorphic features, but 3 patients had flat feet, 2 had urinary incontinence, and 1 had a congenital hindbrain herniation of the cerebellar tonsils. The oldest patient, age 67 years, had other neurologic signs, including pyramidal hypotonia, extensor plantar responses, hypoacusis, and signs of dementia. Carrier women were unaffected.</Attribute>
              <Citation>
                <ID Source="PubMed">17480217</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Intellectual Developmental Disorder, X-linked 29</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX43 family reported by Hamel et al. (1999) with X-linked mental retardation (XLID29; 300419), Bienvenu et al. (2002) identified the 24-bp duplication in exon 2 of the ARX gene.</Attribute>
              <Citation>
                <ID Source="PubMed">10398246</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX76 family reported by Kleefstra et al. (2002), Bienvenu et al. (2002) also identified the same 24-bp duplication.</Attribute>
              <Citation>
                <ID Source="PubMed">12116222</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARX" />
          </GeneList>
          <Name>ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">24-BP DUP, NT428, ALANINE TRACT EXPANSION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300382.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="95290" SubmissionDate="2021-08-23" DateLastUpdated="2021-08-27" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300382.0002_PARTINGTON SYNDROME" title="ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION_PARTINGTON SYNDROME" />
        <ClinVarAccession Accession="SCV000057059" DateUpdated="2021-08-27" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-05-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Developmental and Epileptic Encephalopathy 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Norwegian family described by Stromme et al. (1999), Stromme et al. (2002) found that 7 males with developmental and epileptic encephalopathy (DEE1; 308350), who were clinically diagnosed with infantile spasms/West syndrome, had a 24-bp duplication of nucleotides 429-451 in exon 2. This resulted in a polyalanine expansion from a tract of 12 alanines (amino acids 144-155) to a tract of 20 alanines.</Attribute>
              <Citation>
                <ID Source="PubMed">10353782</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
              <XRef DB="OMIM" ID="308350" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Partington Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stromme et al. (2002) found the same 24-bp duplication in the ARX gene in 2 families with X-linked mental retardation and in 2 families with Partington syndrome (PRTS; 309510). The 2 families in which Partington syndrome was caused by the 24-bp duplication in exon 2 were an Australian family described by Partington et al. (1988) and a Belgian family described by Frints et al. (2002).</Attribute>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3177452</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12376938</ID>
              </Citation>
              <XRef DB="OMIM" ID="309510" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Turner et al. (2002) reviewed the 2 families reported by Stromme et al. (2002) with X-linked mental retardation and the 24-bp duplication. They concluded that the variable expression of the mutation in individuals from both families included manifestations of both West and Partington syndromes. In addition, 1 individual had autism and 2 had autistic behavior, 1 of whom also had epilepsy.</Attribute>
              <Citation>
                <ID Source="PubMed">12376946</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stromme et al. (2003) described bilateral cyst-like cavities in both the cerebral and the cerebellar hemispheres. The patient was a 72-year-old man who lived in a home for the mentally handicapped. He was a member of a family in which X-linked mental retardation was due to a 24-bp duplication in exon 2 the ARX gene.</Attribute>
              <Citation>
                <ID Source="PubMed">12640086</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX36 (see 309510) family reported by Claes et al. (1996) with nonspecific X-linked mental retardation, Bienvenu et al. (2002) identified the 24-bp duplication in exon 2 of the ARX gene. Frints et al. (2002) suggested that the patients reported by Claes et al. (1996) had mild clinical features of PRTS.</Attribute>
              <Citation>
                <ID Source="PubMed">8826464</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12376949</ID>
              </Citation>
              <XRef DB="OMIM" ID="309510" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Polyalanine expansions in 1 of the 2 polyalanine tracts in exon 2 of the ARX gene represent the most frequently occurring mutation in the ARX gene, and interfamilial as well as intrafamilial variability are observed. Van Esch et al. (2004) reported a family in which 4 males with mental retardation had the ARX 24-bp duplication. The proband also had agenesis of the corpus callosum, transsphenoidal encephalocele, and a hypothalamic variant of partial anterior hypopituitarism. The patient had been reported by Grubben et al. (1990) as being born with a median cleft lip and palate and a transsphenoidal encephalocele. One of his affected uncles had dysarthria and dystonic movements of the hands, consistent with Partington syndrome. None of the patients had seizures. Van Esch et al. (2004) noted that congenital basal encephaloceles are very rare and are classified into 4 types, of which the transsphenoidal type is the least frequent (Suwanwela and Suwanwela, 1972). The reported endocrine defects associated with basal encephalocele involve mostly anterior pituitary hormones. The pattern of ARX expression in the brain during embryonic development suggested a causal role for the mutated protein in the origin of the encephalocele in the proband.</Attribute>
              <Citation>
                <ID Source="PubMed">15151512</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2080994</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">5008734</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Partington et al. (2004) reported 3 families with X-linked mental retardation due to the 24-bp duplication in the ARX gene. They reviewed the clinical findings in the 46 MRX patients from 9 families that had been reported with this mutation and noted that mental retardation ranged from mild to severe. Infantile spasms (West syndrome; 308350) occurred in 12.5% and less severe forms of seizures in 37.5%. Characteristic dystonic movements of the hands were seen in 63% and dysarthria in 54%. Partington et al. (2004) suggested that focal dystonia in association with mental retardation may be diagnostic of this mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">15200506</ID>
              </Citation>
              <XRef DB="OMIM" ID="308350" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Poirier et al. (2005) reported 2 brothers with mental retardation who had the 24-bp duplication in the ARX gene and whose healthy sister was heterozygous for the duplication. Their unaffected mother did not apparently carry the mutation, as determined by denaturing high-performance liquid chromatography (DHPLC) and by fragment size analysis, but semiquantitative fluorescent PCR revealed her to be a somatic mosaic, with 4% of her lymphocytes and 24% of her fibroblasts harboring the duplication. Because all 3 of her children received the affected X chromosome, Poirier et al. (2005) suggested that the level of mosaicism might be higher in the mother's germ cells.</Attribute>
              <Citation>
                <ID Source="PubMed">16078051</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stepp et al. (2005) identified the 24-bp duplication in affected individuals from 4 of 11 unrelated families designated as MRX29, MRX32, MRX33, and MRX38 with X-linked mental retardation (300419). The findings suggested that the 24-bp duplication is the most common mutation in nonsyndromic XLMR families linked to Xp22.1.</Attribute>
              <Citation>
                <ID Source="PubMed">15850492</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Laperuta et al. (2007) identified the 24-bp duplication of the ARX gene in 5 affected men from an Italian family designated MRX87 with X-linked mental retardation (300419). There was marked intrafamilial variation with cognitive deficits ranging from moderate to severe. There were no dysmorphic features, but 3 patients had flat feet, 2 had urinary incontinence, and 1 had a congenital hindbrain herniation of the cerebellar tonsils. The oldest patient, age 67 years, had other neurologic signs, including pyramidal hypotonia, extensor plantar responses, hypoacusis, and signs of dementia. Carrier women were unaffected.</Attribute>
              <Citation>
                <ID Source="PubMed">17480217</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Intellectual Developmental Disorder, X-linked 29</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX43 family reported by Hamel et al. (1999) with X-linked mental retardation (XLID29; 300419), Bienvenu et al. (2002) identified the 24-bp duplication in exon 2 of the ARX gene.</Attribute>
              <Citation>
                <ID Source="PubMed">10398246</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX76 family reported by Kleefstra et al. (2002), Bienvenu et al. (2002) also identified the same 24-bp duplication.</Attribute>
              <Citation>
                <ID Source="PubMed">12116222</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARX" />
          </GeneList>
          <Name>ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">24-BP DUP, NT428, ALANINE TRACT EXPANSION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300382.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">PARTINGTON SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3550589" SubmissionDate="2021-08-23" DateLastUpdated="2021-08-27" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey="300382.0002_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29" title="ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29" />
        <ClinVarAccession Accession="SCV001809803" DateUpdated="2021-08-27" DateCreated="2021-08-27" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-05-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Developmental and Epileptic Encephalopathy 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Norwegian family described by Stromme et al. (1999), Stromme et al. (2002) found that 7 males with developmental and epileptic encephalopathy (DEE1; 308350), who were clinically diagnosed with infantile spasms/West syndrome, had a 24-bp duplication of nucleotides 429-451 in exon 2. This resulted in a polyalanine expansion from a tract of 12 alanines (amino acids 144-155) to a tract of 20 alanines.</Attribute>
              <Citation>
                <ID Source="PubMed">10353782</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
              <XRef DB="OMIM" ID="308350" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Partington Syndrome</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stromme et al. (2002) found the same 24-bp duplication in the ARX gene in 2 families with X-linked mental retardation and in 2 families with Partington syndrome (PRTS; 309510). The 2 families in which Partington syndrome was caused by the 24-bp duplication in exon 2 were an Australian family described by Partington et al. (1988) and a Belgian family described by Frints et al. (2002).</Attribute>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3177452</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12376938</ID>
              </Citation>
              <XRef DB="OMIM" ID="309510" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Turner et al. (2002) reviewed the 2 families reported by Stromme et al. (2002) with X-linked mental retardation and the 24-bp duplication. They concluded that the variable expression of the mutation in individuals from both families included manifestations of both West and Partington syndromes. In addition, 1 individual had autism and 2 had autistic behavior, 1 of whom also had epilepsy.</Attribute>
              <Citation>
                <ID Source="PubMed">12376946</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11889467</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stromme et al. (2003) described bilateral cyst-like cavities in both the cerebral and the cerebellar hemispheres. The patient was a 72-year-old man who lived in a home for the mentally handicapped. He was a member of a family in which X-linked mental retardation was due to a 24-bp duplication in exon 2 the ARX gene.</Attribute>
              <Citation>
                <ID Source="PubMed">12640086</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX36 (see 309510) family reported by Claes et al. (1996) with nonspecific X-linked mental retardation, Bienvenu et al. (2002) identified the 24-bp duplication in exon 2 of the ARX gene. Frints et al. (2002) suggested that the patients reported by Claes et al. (1996) had mild clinical features of PRTS.</Attribute>
              <Citation>
                <ID Source="PubMed">8826464</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12376949</ID>
              </Citation>
              <XRef DB="OMIM" ID="309510" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Polyalanine expansions in 1 of the 2 polyalanine tracts in exon 2 of the ARX gene represent the most frequently occurring mutation in the ARX gene, and interfamilial as well as intrafamilial variability are observed. Van Esch et al. (2004) reported a family in which 4 males with mental retardation had the ARX 24-bp duplication. The proband also had agenesis of the corpus callosum, transsphenoidal encephalocele, and a hypothalamic variant of partial anterior hypopituitarism. The patient had been reported by Grubben et al. (1990) as being born with a median cleft lip and palate and a transsphenoidal encephalocele. One of his affected uncles had dysarthria and dystonic movements of the hands, consistent with Partington syndrome. None of the patients had seizures. Van Esch et al. (2004) noted that congenital basal encephaloceles are very rare and are classified into 4 types, of which the transsphenoidal type is the least frequent (Suwanwela and Suwanwela, 1972). The reported endocrine defects associated with basal encephalocele involve mostly anterior pituitary hormones. The pattern of ARX expression in the brain during embryonic development suggested a causal role for the mutated protein in the origin of the encephalocele in the proband.</Attribute>
              <Citation>
                <ID Source="PubMed">15151512</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2080994</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">5008734</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Partington et al. (2004) reported 3 families with X-linked mental retardation due to the 24-bp duplication in the ARX gene. They reviewed the clinical findings in the 46 MRX patients from 9 families that had been reported with this mutation and noted that mental retardation ranged from mild to severe. Infantile spasms (West syndrome; 308350) occurred in 12.5% and less severe forms of seizures in 37.5%. Characteristic dystonic movements of the hands were seen in 63% and dysarthria in 54%. Partington et al. (2004) suggested that focal dystonia in association with mental retardation may be diagnostic of this mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">15200506</ID>
              </Citation>
              <XRef DB="OMIM" ID="308350" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Poirier et al. (2005) reported 2 brothers with mental retardation who had the 24-bp duplication in the ARX gene and whose healthy sister was heterozygous for the duplication. Their unaffected mother did not apparently carry the mutation, as determined by denaturing high-performance liquid chromatography (DHPLC) and by fragment size analysis, but semiquantitative fluorescent PCR revealed her to be a somatic mosaic, with 4% of her lymphocytes and 24% of her fibroblasts harboring the duplication. Because all 3 of her children received the affected X chromosome, Poirier et al. (2005) suggested that the level of mosaicism might be higher in the mother's germ cells.</Attribute>
              <Citation>
                <ID Source="PubMed">16078051</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Stepp et al. (2005) identified the 24-bp duplication in affected individuals from 4 of 11 unrelated families designated as MRX29, MRX32, MRX33, and MRX38 with X-linked mental retardation (300419). The findings suggested that the 24-bp duplication is the most common mutation in nonsyndromic XLMR families linked to Xp22.1.</Attribute>
              <Citation>
                <ID Source="PubMed">15850492</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Laperuta et al. (2007) identified the 24-bp duplication of the ARX gene in 5 affected men from an Italian family designated MRX87 with X-linked mental retardation (300419). There was marked intrafamilial variation with cognitive deficits ranging from moderate to severe. There were no dysmorphic features, but 3 patients had flat feet, 2 had urinary incontinence, and 1 had a congenital hindbrain herniation of the cerebellar tonsils. The oldest patient, age 67 years, had other neurologic signs, including pyramidal hypotonia, extensor plantar responses, hypoacusis, and signs of dementia. Carrier women were unaffected.</Attribute>
              <Citation>
                <ID Source="PubMed">17480217</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Intellectual Developmental Disorder, X-linked 29</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX43 family reported by Hamel et al. (1999) with X-linked mental retardation (XLID29; 300419), Bienvenu et al. (2002) identified the 24-bp duplication in exon 2 of the ARX gene.</Attribute>
              <Citation>
                <ID Source="PubMed">10398246</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
              <XRef DB="OMIM" ID="300419" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In the MRX76 family reported by Kleefstra et al. (2002), Bienvenu et al. (2002) also identified the same 24-bp duplication.</Attribute>
              <Citation>
                <ID Source="PubMed">12116222</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11971879</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARX" />
          </GeneList>
          <Name>ARX, 24-BP DUP, NT428, ALANINE TRACT EXPANSION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">24-BP DUP, NT428, ALANINE TRACT EXPANSION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300382.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1600973" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="3702924|MedGen:C3463992;C0796244" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000829094" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16235064</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20506206</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21204215</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26029707</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17331656</ID>
          </Citation>
          <Comment>This variant, c.428_451dup, results in the insertion of 8 amino acid(s) of the ARX protein (p.Gly143_Ala150dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs387906493, gnomAD 0.02%). This variant has been observed in individual(s) with ARX-related conditions (PMID: 16235064, 20506206, 21204215, 26029707). It has also been observed to segregate with disease in related individuals. This variant is also known as c.441_464 and dup24. ClinVar contains an entry for this variant (Variation ID: 11187). Studies have shown that this variant alters ARX gene expression (PMID: 17331656). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ARX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.25031660_25031661insCGGCCGCGGCTGCCGCGGCGGCCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3463992" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796244" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32170" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1" MappingRef="Preferred">
        <MedGen CUI="C3463992" Name="Developmental and epileptic encephalopathy, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1600973" TraitType="Disease" MappingType="XRef" MappingValue="C0796244" MappingRef="MedGen">
        <MedGen CUI="C0796244" Name="Intellectual disability, X-linked, with or without seizures, arx-related" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1600973" TraitType="Disease" MappingType="XRef" MappingValue="C3463992" MappingRef="MedGen">
        <MedGen CUI="C3463992" Name="Developmental and epileptic encephalopathy, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1107867" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3550589" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29" MappingRef="Alternate">
        <MedGen CUI="C0796244" Name="Intellectual disability, X-linked, with or without seizures, arx-related" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="95290" TraitType="Disease" MappingType="Name" MappingValue="PARTINGTON SYNDROME" MappingRef="Alternate">
        <MedGen CUI="C0796250" Name="Partington syndrome" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-08-27">SCV001805844</Accession>
      </SCV>
      <SCV>
        <Accession Version="5" DateDeleted="2021-08-22">SCV000032172</Accession>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

